Brainstorm Cell Therapeutics | BCLI - Current Assets


Brainstorm Cell Therapeutics reported $307K in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Alterity Therapeutics Limited AUD 37.91M 15.92M Dec/2025
Biogen USD 8.97B 37.5M Dec/2025
Brainstorm Cell Therapeutics USD 307K 201K Dec/2025
Cipla INR 249.18B 16.3B Sep/2025
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 148.02M 59.1M Dec/2025
CSL USD 11.85B 1000K Dec/2025
Cytokinetics USD 916.97M 60.37M Dec/2025
Gilead Sciences USD 19.89B 1.05B Dec/2025
Grifols EUR 5.96B 316.31M Dec/2025
Halozyme Therapeutics USD 825.21M 503.54M Dec/2025
Mesoblast USD 202.48M 1.87M Dec/2025